NCT00501332 2007-12-24Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) ChemotherapyMaxygen Holdings Ltd.Phase 2 Unknown30 enrolled